When it comes to medical diagnosis, I agree that the regulations will slow the adoption rate in the U.S. But then there is China. The Chinese government can collect and share huge amounts of data with less worry about privacy. And looking at the authors of ML papers, you cannot miss Chinese names (though some are U.S.-based, of course).
Your statement about AI copy editors is definitely true (I have some first-hand knowledge about what’s possible but not yet publicly available).
When it comes to medical diagnosis, I agree that the regulations will slow the adoption rate in the U.S. But then there is China. The Chinese government can collect and share huge amounts of data with less worry about privacy. And looking at the authors of ML papers, you cannot miss Chinese names (though some are U.S.-based, of course).
Your statement about AI copy editors is definitely true (I have some first-hand knowledge about what’s possible but not yet publicly available).
Yeah, I’m just talking about the US and probably also Europe for the medical diagnosis part. I don’t have a strong view on what will happen in China.